Skip to content
healthcare.dev

Buspirone Hydrochloride

NDC 64980-652, Buspirone Hydrochloride, tablet, from Rising Pharma Holdings, Inc..

Product NDC
64980-652
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075413
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64980-652 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUSPIRONE HYDROCHLORIDE10 mg/1
Package NDCNDC-11Package
64980-652-0164980065201100 TABLET in 1 BOTTLE (64980-652-01)
64980-652-066498006520660 TABLET in 1 BOTTLE (64980-652-06)
64980-652-5064980065250500 TABLET in 1 BOTTLE (64980-652-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b9aa144c-cb36-4069-9eaa-7c150298cdd7
  • NADAC price for package 64980065201

    GET /v1/drugs/nadac/64980065201
  • NADAC price for package 64980065250

    GET /v1/drugs/nadac/64980065250

Use it

Look up 64980-652 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64980-652 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64980-652. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.